BCYC FY 2019 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$360M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M+93.4% YoY

Gross Profit

-$12M-85.1% margin

Operating Income

-$26M-190.6% margin

Net Income

-$31M-221.8% margin

EPS (Diluted)

$-2.77

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$30M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$110M

Total Liabilities

$17M

Stockholders' Equity

$93M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$7M	+93.4%
Gross Profit	-$12M	-$14M	+13.8%
Operating Income	-$26M	-$22M	-20.9%
Net Income	-$31M	-$22M	-40.1%